Cystic Fibrosis Diagnostic Tests Market – Global Industry Analysis, Growth, Segmentation and Forecast (2023-2029)


Cystic Fibrosis Diagnostic Tests Market is expected to grow at a CAGR of 4% during the forecast period. Global Cystic Fibrosis Diagnostic Tests Market is expected to reach US$ 6.40 Bn. by 2029.

Cystic Fibrosis Diagnostic Tests Market Introduction and Overview

Cystic Fibrosis is an inherited disease, which causes severe damage to the lungs, digestive system, and other organs in the body. It is an autosomal recessive, monogenetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations lead to alterations in protein, causing thick mucus to build up in the lungs and other organs. This causes difficulty in breathing and accumulation of mucus. Germs can thrive on the accumulated mucus causing infection, inflammation and severe respiratory damage.

The increased prevalence of Cystic Fibrosis has led to an increase in the test market. Currently, available tests are new-born screening, Chest X-ray, sweat test, lung functions test, and genetic testing. FDA approval for Trikafta (elexacaftor/ivacaftor/tezacaftor) drug in 2022 boosted the CF tests market by over $1 Bn. The total sales were driven up by 29% to $1.6 Bn.Cystic Fibrosis Diagnostic Tests MarketTo know about the Research Methodology :- Request Free Sample Report

Gene Therapy could offer a comprehensive cure for cystic fibrosis- Innovations in delivering genetic sequences and gene replacement therapies are helping the market to gain momentum. In addition to this, funding’s from non-profit organizations for research and partnerships of top players for developing advanced gene therapies are aiding the market growth at a fast rate. Companies are scouting for new tools and technologies and in the process to boost their product pipelines which in turn will help the market grow.

The report covers the detailed analysis of global Cystic Fibrosis Diagnostic Tests market with the classifications of the market based on test type, End-users, and region. Analysis of past market dynamics from 2018 to 2022 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it.

The report has profiled twenty four key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques. Report has come up with recommendations for future hot spot in APAC region. New research findings, funding policies for projects and its impact on CF Diagnostic Tests market are covered ion the report.

Cystic Fibrosis Diagnostic Tests Market Segment Analysis

The market for Test Type is expected to grow at a CAGR of xx% during the forecast period. The need for diagnosis of the condition at the primary stage is important. The increase in the prevalence of this condition will lead to a rise in the number of tests performed, thereby driving the market growth.

Cystic Fibrosis Diagnostic Tests Market Regional Analysis

North America is expected to contribute a dominant share in the market due to an increase in awareness about Cystic Fibrosis, low test costs, and highly developed infrastructure followed by Europe by 2029.

Whereas in the APAC region, the market is likely to grow at a CAGR of xx% during the forecast period. Increasing cases of patients with inflammatory bowel diseases and developing healthcare infrastructure are elevating the market.

The objective of the report is to present a comprehensive analysis of the global market of all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding global market dynamics, structure by analysing the market segments and project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in global market make the report investor’s guide.

Cystic Fibrosis Diagnostic Tests Market Scope: Inquire before buying






Cystic Fibrosis Diagnostic Tests Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 4.86 Bn.




Forecast Period 2023 to 2029 CAGR:
4%
Market Size in 2029:
US $ 6.40 Bn.




 Segments Covered:
by Type
Genetic Tests
Faecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary function Tests




by End-user
Hospitals
Diagnostics
Laboratories
Others






Cystic Fibrosis Diagnostic Tests Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Cystic Fibrosis Diagnostic Tests Market Key Players:

1. Quidel Corporation
2. Quest Diagnostics
3. Vertex Pharmaceuticals
4. Verona Pharma
5. Abbott Laboratories
6. Pfizer Inc
7. Novartis
8. Creative Diagnostics
9. Invitae Corporation
10. Asper Biogene
11. GeneDx
12. Illumina Inc
13. Elucigene Diagnostics
14. BillionToOne Inc
15. ELITech Group
16. NovaBiotics Ltd
17. Cystic Fibrosis Foundation Therapeutics, Inc
18. Galapagos NV
19. AbbVie
20. Gilead Sciences
21. F.Hoffman La Roche
22. Forest Laboratories
23. Genentech
24. Pharmaxis

Frequently Asked Questions:

1. Which region has the largest share in Global Cystic Fibrosis Diagnostic Tests Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Cystic Fibrosis Diagnostic Tests Market?
Ans: The Global Cystic Fibrosis Diagnostic Tests Market is growing at a CAGR of 4% during forecasting period 2023-2029.

3. What is scope of the Global Cystic Fibrosis Diagnostic Tests Market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Cystic Fibrosis Diagnostic Tests Market?
Ans: The important key players in the Global Cystic Fibrosis Diagnostic Tests Market are – Quidel Corporation, Quest Diagnostics, Vertex Pharmaceuticals, Verona Pharma, Abbott Laboratories, Pfizer Inc, Novartis, Creative Diagnostics, Invitae Corporation, Asper Biogene,

5. What is the study period of this Market?
Ans: The Global Cystic Fibrosis Diagnostic Tests Market is studied from 2022 to 2029. 




Global Cystic Fibrosis Diagnostic Tests Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size, By Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis and Forecast
6.1. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis and Forecast, By Test Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type
7.4. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size (US$ Mn) Forecast, By Test Type
7.5. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Test Type
7.6. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis, By Test Type

8. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis and Forecast, By End-user
8.1. Introduction and Definition
8.2. Key Findings
8.3. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user
8.4. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size (US$ Mn) Forecast, By End-user
8.5. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By End-user
8.6. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis, By End-user

9. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Region
9.1. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Region
9.2. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size (US$ Mn) Forecast, By Region
9.3. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis, By Region

10. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis
10.1. Key Findings
10.2. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview
10.3. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type
10.4. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
10.4.1. Genetic Tests
10.4.2. Faecal Test
10.4.3. Immunoreactive Trypsinogen (IRT) Test
10.4.4. Sweat Chloride Tests
10.4.5. Pulmonary function Tests
10.5. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user
10.6. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
10.6.1. Hospitals
10.6.2. Diagnostics
10.6.3. Laboratories
10.6.4. Others
10.7. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country
10.8. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country
10.8.1. U.S.
10.8.2. Canada
10.8.3. Mexico
10.9. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country
10.10. U.S. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
10.10.1. Genetic Tests
10.10.2. Faecal Test
10.10.3. Immunoreactive Trypsinogen (IRT) Test
10.10.4. Sweat Chloride Tests
10.10.5. Pulmonary function Tests
10.11. U.S. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
10.11.1. Hospitals
10.11.2. Diagnostics
10.11.3. Laboratories
10.11.4. Others
10.12. Canada CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
10.12.1. Genetic Tests
10.12.2. Faecal Test
10.12.3. Immunoreactive Trypsinogen (IRT) Test
10.12.4. Sweat Chloride Tests
10.12.5. Pulmonary function Tests
10.13. Canada CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
10.13.1. Hospitals
10.13.2. Diagnostics
10.13.3. Laboratories
10.13.4. Others
10.14. Mexico CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
10.14.1. Genetic Tests
10.14.2. Faecal Test
10.14.3. Immunoreactive Trypsinogen (IRT) Test
10.14.4. Sweat Chloride Tests
10.14.5. Pulmonary function Tests
10.15. Mexico CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
10.15.1. Hospitals
10.15.2. Diagnostics
10.15.3. Laboratories
10.15.4. Others
10.16. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis
10.16.1. By Test Type
10.16.2. By End-user
10.17. PEST Analysis
10.18. Key Trends
10.19. Key Developments

11. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis
11.1. Key Findings
11.2. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview
11.3. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type
11.4. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.4.1. Genetic Tests
11.4.2. Faecal Test
11.4.3. Immunoreactive Trypsinogen (IRT) Test
11.4.4. Sweat Chloride Tests
11.4.5. Pulmonary function Tests
11.5. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user
11.6. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.6.1. Hospitals
11.6.2. Diagnostics
11.6.3. Laboratories
11.6.4. Others
11.7. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country
11.8. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Sweden
11.8.7. CIS countries
11.8.8. Rest of Europe
11.9. Germany CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.9.1. Genetic Tests
11.9.2. Faecal Test
11.9.3. Immunoreactive Trypsinogen (IRT) Test
11.9.4. Sweat Chloride Tests
11.9.5. Pulmonary function Tests
11.10. Germany CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.10.1. Hospitals
11.10.2. Diagnostics
11.10.3. Laboratories
11.10.4. Others
11.11. U.K. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.11.1. Genetic Tests
11.11.2. Faecal Test
11.11.3. Immunoreactive Trypsinogen (IRT) Test
11.11.4. Sweat Chloride Tests
11.11.5. Pulmonary function Tests
11.12. U.K. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.12.1. Hospitals
11.12.2. Diagnostics
11.12.3. Laboratories
11.12.4. Others
11.13. France CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.13.1. Genetic Tests
11.13.2. Faecal Test
11.13.3. Immunoreactive Trypsinogen (IRT) Test
11.13.4. Sweat Chloride Tests
11.13.5. Pulmonary function Tests
11.14. France CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.14.1. Hospitals
11.14.2. Diagnostics
11.14.3. Laboratories
11.14.4. Others
11.15. Italy CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.15.1. Genetic Tests
11.15.2. Faecal Test
11.15.3. Immunoreactive Trypsinogen (IRT) Test
11.15.4. Sweat Chloride Tests
11.15.5. Pulmonary function Tests
11.16. Italy CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.16.1. Hospitals
11.16.2. Diagnostics
11.16.3. Laboratories
11.16.4. Others
11.17. Spain CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.17.1. Genetic Tests
11.17.2. Faecal Test
11.17.3. Immunoreactive Trypsinogen (IRT) Test
11.17.4. Sweat Chloride Tests
11.17.5. Pulmonary function Tests
11.18. Spain CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.18.1. Hospitals
11.18.2. Diagnostics
11.18.3. Laboratories
11.18.4. Others
11.19. Sweden CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.19.1. Genetic Tests
11.19.2. Faecal Test
11.19.3. Immunoreactive Trypsinogen (IRT) Test
11.19.4. Sweat Chloride Tests
11.19.5. Pulmonary function Tests
11.20. Sweden CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.20.1. Hospitals
11.20.2. Diagnostics
11.20.3. Laboratories
11.20.4. Others
11.21. CIS countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.21.1. Genetic Tests
11.21.2. Faecal Test
11.21.3. Immunoreactive Trypsinogen (IRT) Test
11.21.4. Sweat Chloride Tests
11.21.5. Pulmonary function Tests
11.22. CIS countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.22.1. Hospitals
11.22.2. Diagnostics
11.22.3. Laboratories
11.22.4. Others
11.23. Rest of Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
11.23.1. Genetic Tests
11.23.2. Faecal Test
11.23.3. Immunoreactive Trypsinogen (IRT) Test
11.23.4. Sweat Chloride Tests
11.23.5. Pulmonary function Tests
11.24. Rest of Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
11.24.1. Hospitals
11.24.2. Diagnostics
11.24.3. Laboratories
11.24.4. Others
11.25. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis
11.25.1. By End-user
11.25.2. By Test Type
11.26. PEST Analysis
11.27. Key Trends
11.28. Key Developments

12. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis
12.1. Key Findings
12.2. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview
12.3. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type
12.4. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.4.1. Genetic Tests
12.4.2. Faecal Test
12.4.3. Immunoreactive Trypsinogen (IRT) Test
12.4.4. Sweat Chloride Tests
12.4.5. Pulmonary function Tests
12.5. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user
12.6. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.6.1. Hospitals
12.6.2. Diagnostics
12.6.3. Laboratories
12.6.4. Others
12.7. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country
12.8. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. South Korea
12.8.5. Australia
12.8.6. ASEAN
12.8.7. Rest of Asia Pacific
12.9. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country
12.10. China CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.10.1. Genetic Tests
12.10.2. Faecal Test
12.10.3. Immunoreactive Trypsinogen (IRT) Test
12.10.4. Sweat Chloride Tests
12.10.5. Pulmonary function Tests
12.11. China CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.11.1. Hospitals
12.11.2. Diagnostics
12.11.3. Laboratories
12.11.4. Others
12.12. India CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.12.1. Genetic Tests
12.12.2. Faecal Test
12.12.3. Immunoreactive Trypsinogen (IRT) Test
12.12.4. Sweat Chloride Tests
12.12.5. Pulmonary function Tests
12.13. India CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.13.1. Hospitals
12.13.2. Diagnostics
12.13.3. Laboratories
12.13.4. Others
12.14. Japan CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.14.1. Genetic Tests
12.14.2. Faecal Test
12.14.3. Immunoreactive Trypsinogen (IRT) Test
12.14.4. Sweat Chloride Tests
12.14.5. Pulmonary function Tests
12.15. Japan CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.15.1. Hospitals
12.15.2. Diagnostics
12.15.3. Laboratories
12.15.4. Others
12.16. South Korea CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.16.1. Genetic Tests
12.16.2. Faecal Test
12.16.3. Immunoreactive Trypsinogen (IRT) Test
12.16.4. Sweat Chloride Tests
12.16.5. Pulmonary function Tests
12.17. South Korea CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.17.1. Hospitals
12.17.2. Diagnostics
12.17.3. Laboratories
12.17.4. Others
12.18. Australia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.18.1. Genetic Tests
12.18.2. Faecal Test
12.18.3. Immunoreactive Trypsinogen (IRT) Test
12.18.4. Sweat Chloride Tests
12.18.5. Pulmonary function Tests
12.19. Australia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.19.1. Hospitals
12.19.2. Diagnostics
12.19.3. Laboratories
12.19.4. Others
12.20. ASEAN CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.20.1. Genetic Tests
12.20.2. Faecal Test
12.20.3. Immunoreactive Trypsinogen (IRT) Test
12.20.4. Sweat Chloride Tests
12.20.5. Pulmonary function Tests
12.21. ASEAN CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.21.1. Hospitals
12.21.2. Diagnostics
12.21.3. Laboratories
12.21.4. Others
12.22. Rest of Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
12.22.1. Genetic Tests
12.22.2. Faecal Test
12.22.3. Immunoreactive Trypsinogen (IRT) Test
12.22.4. Sweat Chloride Tests
12.22.5. Pulmonary function Tests
12.23. Rest of Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
12.23.1. Hospitals
12.23.2. Diagnostics
12.23.3. Laboratories
12.23.4. Others
12.24. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis
12.24.1. By Test Type
12.24.2. By End-user
12.25. PEST Analysis
12.26. Key Trends
12.27. Key Developments

13. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis
13.1. Key Findings
13.2. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview
13.3. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type
13.4. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
13.4.1. Genetic Tests
13.4.2. Faecal Test
13.4.3. Immunoreactive Trypsinogen (IRT) Test
13.4.4. Sweat Chloride Tests
13.4.5. Pulmonary function Tests
13.5. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user
13.6. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
13.6.1. Hospitals
13.6.2. Diagnostics
13.6.3. Laboratories
13.6.4. Others
13.7. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country
13.8. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country
13.8.1. GCC Countries
13.8.2. South Africa
13.8.3. Nigeria
13.8.4. Egypt
13.8.5. Rest of Middle East & Africa
13.9. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country
13.10. GCC Countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
13.10.1. Genetic Tests
13.10.2. Faecal Test
13.10.3. Immunoreactive Trypsinogen (IRT) Test
13.10.4. Sweat Chloride Tests
13.10.5. Pulmonary function Tests
13.11. GCC Countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
13.11.1. Hospitals
13.11.2. Diagnostics
13.11.3. Laboratories
13.11.4. Others
13.12. South Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
13.12.1. Genetic Tests
13.12.2. Faecal Test
13.12.3. Immunoreactive Trypsinogen (IRT) Test
13.12.4. Sweat Chloride Tests
13.12.5. Pulmonary function Tests
13.13. South Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
13.13.1. Hospitals
13.13.2. Diagnostics
13.13.3. Laboratories
13.13.4. Others
13.14. Nigeria CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
13.14.1. Genetic Tests
13.14.2. Faecal Test
13.14.3. Immunoreactive Trypsinogen (IRT) Test
13.14.4. Sweat Chloride Tests
13.14.5. Pulmonary function Tests
13.15. Nigeria CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
13.15.1. Hospitals
13.15.2. Diagnostics
13.15.3. Laboratories
13.15.4. Others
13.16. Egypt CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
13.16.1. Genetic Tests
13.16.2. Faecal Test
13.16.3. Immunoreactive Trypsinogen (IRT) Test
13.16.4. Sweat Chloride Tests
13.16.5. Pulmonary function Tests
13.17. Egypt CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
13.17.1. Hospitals
13.17.2. Diagnostics
13.17.3. Laboratories
13.17.4. Others
13.18. Rest of Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
13.18.1. Genetic Tests
13.18.2. Faecal Test
13.18.3. Immunoreactive Trypsinogen (IRT) Test
13.18.4. Sweat Chloride Tests
13.18.5. Pulmonary function Tests
13.19. Rest of Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
13.19.1. Hospitals
13.19.2. Diagnostics
13.19.3. Laboratories
13.19.4. Others
13.20. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis
13.20.1. By Test Type
13.20.2. By End-user
13.21. PEST Analysis
13.22. Key Trends
13.23. Key Developments

14. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis
14.1. Key Findings
14.2. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview
14.3. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type
14.4. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
14.4.1. Genetic Tests
14.4.2. Faecal Test
14.4.3. Immunoreactive Trypsinogen (IRT) Test
14.4.4. Sweat Chloride Tests
14.4.5. Pulmonary function Tests
14.5. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user
14.6. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
14.6.1. Hospitals
14.6.2. Diagnostics
14.6.3. Laboratories
14.6.4. Others
14.7. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country
14.8. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country
14.8.1. Brazil
14.8.2. Colombia
14.8.3. Argentina
14.8.4. Rest of South America
14.9. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country
14.10. Brazil CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
14.10.1. Genetic Tests
14.10.2. Faecal Test
14.10.3. Immunoreactive Trypsinogen (IRT) Test
14.10.4. Sweat Chloride Tests
14.10.5. Pulmonary function Tests
14.11. Brazil CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
14.11.1. Hospitals
14.11.2. Diagnostics
14.11.3. Laboratories
14.11.4. Others
14.12. Colombia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
14.12.1. Genetic Tests
14.12.2. Faecal Test
14.12.3. Immunoreactive Trypsinogen (IRT) Test
14.12.4. Sweat Chloride Tests
14.12.5. Pulmonary function Tests
14.13. Colombia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
14.13.1. Hospitals
14.13.2. Diagnostics
14.13.3. Laboratories
14.13.4. Others
14.14. Argentina CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
14.14.1. Genetic Tests
14.14.2. Faecal Test
14.14.3. Immunoreactive Trypsinogen (IRT) Test
14.14.4. Sweat Chloride Tests
14.14.5. Pulmonary function Tests
14.15. Argentina CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
14.15.1. Hospitals
14.15.2. Diagnostics
14.15.3. Laboratories
14.15.4. Others
14.16. Rest of South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type
14.16.1. Genetic Tests
14.16.2. Faecal Test
14.16.3. Immunoreactive Trypsinogen (IRT) Test
14.16.4. Sweat Chloride Tests
14.16.5. Pulmonary function Tests
14.17. Rest of South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user
14.17.1. Hospitals
14.17.2. Diagnostics
14.17.3. Laboratories
14.17.4. Others
14.18. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis
14.18.1. By Test Type
14.18.2. By End-user
14.19. PEST Analysis
14.20. Key Trends
14.21. Key Developments

15. Company Profiles
15.1. Market Share Analysis, By Company
15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players By price, presence, market share, End-user, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A By Regions, Investment and End-user
15.2.3.2. M&A Key Players, Forward Integration and Backward Integration

15.3. Company Profiles: Key Players
15.3.1. Quidel Corporation
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Quest Diagnostics
15.3.3. Vertex Pharmaceuticals
15.3.4. Verona Pharma
15.3.5. Abbott Laboratories
15.3.6. Pfizer Inc
15.3.7. Novartis
15.3.8. Creative Diagnostics
15.3.9. Invitae Corporation
15.3.10. Asper Biogene
15.3.11. GeneDx
15.3.12. Illumina Inc
15.3.13. Elucigene Diagnostics
15.3.14. BillionToOne Inc
15.3.15. ELITech Group
15.3.16. NovaBiotics Ltd
15.3.17. Cystic Fibrosis Foundation Therapeutics, Inc
15.3.18. Galapagos NV
15.3.19. AbbVie
15.3.20. Gilead Sciences
15.3.21. F.Hoffman La Roche
15.3.22. Forest Laboratories
15.3.23. Genentech
15.3.24. Pharmaxis
  • INQUIRE BEFORE BUYING